The Pharmafocus Interview: Jan Lundberg AstraZeneca's global head of drug discovery talks about new compounds, learning from mistakes and the real heroes behind life-saving drugs.(more)
Emerging confidence Evidence-based medicine is an evolving practice, even in the developed world, but proving value is getting tougher in emerging markets too, says Ben Shankland(more)
Are you structured for success? Friday , June 18, 2004
To become truly customer focused, the industry needs its non-marketers to adopt a marketing mindset and move away from traditional organisational structures....(more)
CROs: flexible or overstretched? Thursday , June 03, 2004
The best contract research organisations are past masters in drug development - but make sure they have the strength and depth to deliver on their promises....(more)
Unmet needs in arthritis Thursday , June 03, 2004
The pricing of a new generation of novel rheumatoid arthritis treatments could undercut current therapies, but doctors still want products that are even safer....(more)
Lost in translation? Wednesday, June 02, 2004
As concerns persist about the effects of the EU Clinical Trials Directive, pharma will need to work with the non-commercial sector and regulators to keep UK R&D healthy....(more)
The science of compliance Tuesday , June 01, 2004
Learning lessons from some of the fundamental traits of human psychology can help pharma and healthcare professionals ensure greater patient medicines compliance....(more)
Counterfeit medicines on the rise Tuesday , June 01, 2004
The industry is facing up to the major patient safety issue of counterfeit medicines - authentication at the point of dispensing is the way to solve the problem....(more)
Making the most of your talent Tuesday , June 01, 2004
Managing the flow of resources to the various products in your portfolio can present you with some difficult decisions, so how well does pharma cope with this?...(more)
